Eczema Clinical Trial
Official title:
A Randomised Clinical Trial on the Effect of Group Education on Skin-protective Behaviour Versus Treatment as Usual Among Individuals With Newly Notified Occupational Hand Eczema
Occupational hand eczema (OHE) is a frequent disease which often takes a chronic course. The
burden of the disease is high in a personal as well as in a socio-economic context. There is
a need for evaluating new strategies to improve the prognosis for OHE patients. The
objectives of the study is to evaluate the effect of group education on sick lave,
health-related quality of life and disease severity among individuals with newly notified
OHE.
The trial population consist of individuals from the Capital Region of Denmark and Region
Zealand with a suspected skin-related industrial injury notified to the Danish National
Board of Industrial Injuries (DNBII). Recruitment is started Juli 2012, and will continue
until the designed number of participants have been included.
All participants will be assessed in a questionnaire at time T=0 with regard to: self
evaluated disease severity, health-related quality of life, skin protective behaviour,
knowledge of skin protection, self-efficacy, work-role function and if active in workforce.
The participants will then be randomised. The intervention group will be invited to
participate in the educative course, and work place visits will be offered. In the
intervention group a telephone hot line will be available for further questions concerning
these topics. The control group will not have access to any of these interventions. Both
intervention group and control group will be contacted every eighth week about number of
days of sick leave/absence from workforce. Both groups are re-assessed using a questionnaire
at T=12 months. There will be a total of 742 included participants.
The hypotheses of the PREVEX trial are:
- Early information build on evidence-based skin-protection programmes and work-place
visits with counselling in skin care, followed by telephone hotline, will give the
participants increased level of knowledge concerning the treatment and prevention of
OHE.
- Increased level of knowledge concerning prevention and focus on skin care will have a
positive impact on skin-protective behaviour and will lower the severity of HE and
prevent the development of chronic eczema.
- The decrease in severity of HE will decrease sick leave and keep the participants in
job, or prevent job loss, or facilitate the re-entry into the workforce.
- In total, the intervention will have a positive effect on health-related quality of
life.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01257061 -
Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment
|
Phase 3 | |
Completed |
NCT03563066 -
Effect of Benralizumab in Atopic Dermatitis
|
Phase 2 | |
Withdrawn |
NCT03089476 -
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
|
N/A | |
Recruiting |
NCT04818138 -
BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort
|
N/A | |
Recruiting |
NCT05439577 -
A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema
|
||
Completed |
NCT02916888 -
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
|
N/A | |
Completed |
NCT02075632 -
Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream
|
Phase 2 | |
Completed |
NCT00143819 -
Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis
|
Phase 2 | |
Recruiting |
NCT01631617 -
Effects of Treatments on Atopic Dermatitis
|
Phase 2 | |
Completed |
NCT04358224 -
The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
|
Phase 4 | |
Not yet recruiting |
NCT04520308 -
An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
|
Phase 4 | |
Recruiting |
NCT03340155 -
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases
|
N/A | |
Completed |
NCT04023084 -
Response of Children With Atopic Dermatitis (Eczema) to Eucrisa
|
Phase 4 | |
Completed |
NCT03720470 -
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
|
Phase 3 | |
Completed |
NCT05583019 -
Atopic Dermatitis With Accelerometry and Polysomnography (ADAP)
|
||
Completed |
NCT03293030 -
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
|
Phase 4 | |
Completed |
NCT02002871 -
Blue Light for Treating Eczema
|
N/A | |
Completed |
NCT01420705 -
Bacille Calmette-Guérin (BCG) Vaccine and Atopy
|
N/A | |
Recruiting |
NCT01012453 -
A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema
|
N/A | |
Completed |
NCT00375713 -
Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema
|
Phase 3 |